Asciminib in chronic myeloid leukemia: a STAMP for expedited delivery?

Haematologica · 2023 · PMC10620583 · PMID 37102603

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a numerical trendno p-value reported

There were also imbalances in the two cohorts (e.g., a numerical trend for more patients that had received ponatinib and more TKI, or were resistant vs . intolerant in the bosutinib cohort).

also in 665 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.